2011–12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hospitals. A Pilot Study

• Marc Rondy ,

  * E-mail: m.rondy@epiconcept.fr

  Affiliation EpiConcept, Paris, France

  ⨯
• Joan Puig-Barbera,

  Affiliations Centro Superior de Investigación en Salud Pública (CSISP), Valencia, Spain, Centro de Salud Pública de Castellón, Castellón, Spain

  ⨯
• Odile Launay,

  Affiliations Institut national de la santé et de la recherche médicale (Inserm), Réseau National d’Investigation Clinique en Vaccinologie (REIVAC), Paris, France, Université Paris Descartes, Paris, France, Inserm, Centre d’investigation Clinique (CIC) de Vaccinologie Cochin Pasteur BT505, Paris, France, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France

  ⨯
• Xavier Duval,

  Affiliations Institut national de la santé et de la recherche médicale (Inserm), Réseau National d’Investigation Clinique en Vaccinologie (REIVAC), Paris, France, Inserm, CIC 007; AP-HP, Hôpital Bichat Claude Bernard, Paris, France

  ⨯
• Jesús Castilla,

  Affiliations Instituto de Salud Pública de Navarra, Pamplona, Spain, Centros de Investigación Biomédica en Red (CIBER), Epidemiología y Salud Pública, Barcelona, Spain

  ⨯
• Marcela Guevara,

  Affiliations Instituto de Salud Pública de Navarra, Pamplona, Spain, Centros de Investigación Biomédica en Red (CIBER), Epidemiología y Salud Pública, Barcelona, Spain

  ⨯
• Simona Costanzo,

  Affiliation Laboratory of Genetic and Environmental Epidemiology, Research Laboratories, Fondazione di Ricerca e Cura “Giovanni Paolo II”, Campobasso, Italy

  ⨯
• Katleen de Gaetano Donati,

  Affiliation Department of Infectious Disease, Catholic University, Rome, Italy

  ⨯
• Alain Moren

  Affiliation EpiConcept, Paris, France

  ⨯